Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the physiological actions of GLP-1, a hormone released by https://hylistings.com/story22058854/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes